No exits recorded yet.
0 funds tracked, 0 portfolio companies (0 active · 0 realized). Verified weekly from public filings and deal announcements.
EKA Ventures is the UK's largest early-stage impact venture capital firm with approximately $200 million of total assets across Fund I and Fund II as of December 2024 (Fund II $107 million / £80 million closed late 2024 / early 2025), headquartered in London. The firm was founded in 2018 by Jon Huggins and Camilla Richards and operates as a partner-owned independent FCA-regulated (FRN 848631) B Corp certified VC.
EKA Ventures deploys capital through two flagship funds (Fund I 2020, Fund II 2024-2025), targeting pre-seed and seed-stage UK impact venture capital leading or co-leading 90% of deals with approximately $2 million average initial cheque across consumer-led mega trends spanning Life, Health and Sustainability. Sector focus spans consumer health and femtech, climate tech, sustainable supply chains, preventative healthcare, consumer goods and fintech and legaltech. Fund II plans up to 30 UK startups. Geographic deployment is UK-focused. The founder-aligned thought partner model provides strategic guidance beyond capital.
Recent realised exits include consumer health and fitness apps (Runna acquired by Strava, April 2025). Recent acquisitions include femtech and menstrual health (DITTO Daily £1.35 million pre-seed lead, August 2025) plus active deployment across Hived (last-mile logistics), Jude (urinary health), Flok Health (musculoskeletal AI) and Foresight Data Machines. The platform continues active deployment of Fund II across the UK impact thesis. Detailed buyer names and multiple data available on Pro at €49/month.
Other private equity firms tracked on GP Intel.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in